In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bio Products Laboratory Ltd.

Latest From Bio Products Laboratory Ltd.

DiaSorin Strikes Dx Partnership With MeMed To Address Antibiotic Overuse

First licensing agreement for MeMed adds its immune system-based protein signature test to DiaSorin’s LIAISON test menu.

Infectious Diseases Deals

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

European Notebook: Shake-Up At EMA, Restructuring At Pierre Fabre, Reinhardt Returns To Novartis

A new leadership team at EMA to be unveiled in September; the death of Pierre Fabre leads to management restructuring at France's third largest pharma; Reinhardt to review strategy as he replaces Vasella at the Swiss multinational, Novartis; and more…

BioPharmaceutical Europe

Korea’s Green Cross Anticipates Growth In Upcoming Flu Season

The upcoming flu season should provide more momentum to Korea’s leading vaccine company, which saw marginal year-on-year growth in the second quarter.

BioPharmaceutical South Korea
See All

Company Information

  • Industry
  • Biotechnology
  • Distributors
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • BPL Group
    • Creat Group Corporation